METALS AND MINING
Perseus Mining (ASX: PRU) provided an update on growth projects it is exploring at its Yaouré Gold Project in Côte d’Ivoire, including results from ongoing resource definition drilling, deposit reconciliation performance, and planned work programs.
Iltani Resources (ASX: ILT) completed first-pass ore sorting at its Orient silver-indium project in northern Queensland which produced a high-grade sulphide product from both high and low-grade samples in a single sort. These first-pass tests were undertaken to establish proof-of-concept. Larger-scale bulk sorting test work will follow using PQ (85mm diameter) diamond core. Iltani is planning a seven-hole PQ diamond drilling program to generate samples for the next phase of test work.
Magmatic Resources (ASX: MAG) reported strong Phase 3 drilling results at the Weebo Gold Project, with best result of 6m @ 3.4 g/t Au including 1m @ 13.9 g/g Au. The results confirmed bedrock gold mineralisation at Otto 2 and Ockerburry 3, shallow gold mineralisation at Scone Stone, identified five regional-scale gold-bearing structures through aircore drilling, and advanced priority targets ahead of follow-up drilling in September–October. Covered by Mining.com.au and Australian Resources and Investment.
Sunshine Metals (ASX: SHN) identified new high-grade gold targets at its Sybil Gold Project in Queensland after completing the first detailed airborne magnetic and radiometric survey across the project. The survey defined new epithermal vein targets at Cisco and Pancho, where follow-up rock chip sampling returned grades of up to 21.6g/t gold and 6.04g/t gold, while also identifying large-scale fault structures and buried intrusions associated with mineralisation. RC drilling is scheduled to commence at Francis Creek East this week to test the newly generated targets. Covered by Mining.com.au.
Power Minerals (ASX: PNN) completed the first two drillholes of its maiden diamond drilling program at the Morro do Ferro Rare Earths Project in Brazil, with a third hole underway and a second drill rig set to accelerate the campaign. The company has recovered 487.8m of core at an average 94.5% recovery, dispatched its first samples for assay, completed a drone geophysical survey across the project area, and remains on track to deliver a JORC 2012 Mineral Resource Estimate later this year. Covered by Stockhead.
Enova Mining (ASX: ENV) confirmed thick saprolite-hosted rare earth mineralisation at its Charley Creek Project in the Northern Territory, with drilling validating multiple broad intercepts and high-grade zones within the weathered saprolite profile. Best results included 25.6m at 1,583ppm TREO from 39m (including 6m at 4,684ppm TREO) and 12m at 1,519ppm TREO from 36m (including 3m at 3,013ppm TREO), while peak assays reached 8,218ppm TREO. The drilling also confirmed that the underlying fresh basement rock is not the source of mineralisation in the current target area.
Falcon Metals (ASX: FAL) reported further growth at its Blue Moon Gold Project in Victoria, with mineralisation now confirmed over more than 750m of strike and a fifth stacked gold-bearing structure identified. The results included high-grade visible gold intercepts in the Jasmine Zone and the discovery above Jasmine of Blue Moon’s fifth stacked structure, the Magnolia Zone. The drill program continues 24/7 with three diamond rigs, including two rigs completing step-out drilling north along the Garden Gully line.
Kali Metals (ASX: KM1) returned high-grade rock chip results at its Marble Bar Gold Project in WA, supporting further work to advance four new gold prospects towards drilling. During May and June, Kali collected 48 rock-chip samples with the aim of identifying new gold prospects and finding new extensions of mineralisation at the Tiger, Churchill and Sherman prospects.
Heavy Rare Earths (ASX: HRE) announced encouraging preliminary results from the strategic review of its Subron Rare Earths Project in WA (formerly Cowalinya). Highlights include significant high-grade mineralisation, elevated TREO and HREO grades, and a peak HREO ratio of 70%. Covered by Market Open and Stockhead.
Everest Metals (ASX: EMC) secured a Mining Lease for the Revere Gold Project in Western Australia’s Murchison Region, securing the key tenure required to progress the project towards development. The lease encompasses the entire Big John Mineral Resource and marks a significant step forward in advancing Revere from exploration into the next phase of technical studies, statutory approvals, and mine development. Covered by Stockhead.
Krakatoa Resources (ASX: KTA) reported resource definition drilling is advancing with four surface and 13 underground diamond drill holes completed at its Zopkhito Antimony-Gold Project, with initial assays in the process of being transported to the laboratory. Specialist mining and JORC consultants have been on-site to complete a geological review of the drill core, historical datasets and underground workings. Covered by Proactive and Mining.com.
Golden Dragon Mining (ASX: GDR) announced regional-scale gold anomalies have been identified from its recent auger drilling program at the Coodardy/Behring Bore area, part of the Company’s Cue Gold Project in the Murchison Goldfields of Western Australia.
Novo Resources (ASX: NVO) provided an update on the recent exploration and progress across its Pilbara project portfolio, including an expanded landholding at the Toolunga Copper–Gold Project where Novo has identified three IOCG style targets, the completion of the maiden Wyloo Polymetallic Project drilling at the Wyloo SE prospect, as well as new soil and rock chip sample results from the Vera anomaly.
Evergold Minerals (ASX: EG1) commenced an aircore drilling program at the Mt Monger Gold Project in WA, marking the next phase of its systematic exploration strategy following the successful maiden reverse circulation drilling campaign at Duchess of York. The 13,000m+ program is designed to test shallow extensions of known mineralisation, identify additional mineralised structures, and evaluate multiple regional targets generated through Evergold's integrated geological model. Covered by Mining.com.au, The Market Bull & Mining Herald.
Strata Minerals (ASX: SMX) continues to advance its 100%-owned Zelica Gold Project in Western Australia with the acquisition and staking of two additional highly prospective tenements, expanding the Project footprint. A high-resolution airborne magnetic survey will shortly commence across the expanded area, aimed at enhancing geological understanding, defining new drill targets and unlocking further exploration potential within the broader gold system. Covered by Stockhead.
Koba Resources (ASX: KOB) completed its inaugural tungsten-focused sampling program at the Mt Garnet Tin-Tungsten Project in Queensland, with outstanding assays of up to 13.2% W, 5.4% W and 5.0% W returned from six priority prospects, highlighting the project's strong tungsten potential.
BOA Resources (ASX: BOA) is preparing to commence maiden drilling at Neds Creek Copper Project in WA following completion of heritage surveys, drill contracts signed and PoWs received for the program. BOA has planned a 7,500m 53-hole reverse circulation drill program with the Ricci Lee prospect confirmed as first priority target, where BOA plans to define a maiden copper resource, following its recent acquisition of the Thaduna and Green Dragon copper deposits, which contain a combined Mineral Resource Estimate of 5.3Mt @ 2.3% Cu for 121kt contained Cu.
Vita Resources (ASX: VTA) is set to resume the maiden exploration programme at its Ninnis Gold Project in WA in early August 2026. The programme has been expanded to include approximately 300 infill holes in addition to the remaining ~350 holes yet to be completed.
INDUSTRIAL
Metal Powder Works (ASX: MPW) appointed Dr Ahmed El Desouky as Chief Operating Officer to strengthen its executive team and support the next phase of commercial scale-up. Dr El Desouky, a PhD-qualified metallurgist with 15 years of advanced manufacturing leadership, joins from Veeco Instruments (NASDAQ: VECO), where he led operations, quality, supply chain, and scaled the company’s additive manufacturing function from startup to production-ready. His expertise is expected to support MPW’s transition to commercial-scale powder production, improve yields, build robust operational infrastructure, and advance customer qualifications for its patented DirectPowder™ technology.
BPH Global (ASX: BP8) completed the first direct commercial shipment of raw seaweed from Indonesia to a customer in China through its Indonesian subsidiary, PT BPH Global Indonesia. The shipment follows GACC approval under the Indonesia–China Mutual Recognition Arrangement and establishes a direct export channel into one of the world’s largest seaweed markets. Direct sales to China are expected to improve realised selling prices and strengthen the Company’s trading margins.
ECS Botanics (ASX: ECS) delivered a fourth consecutive positive operating cash flow quarter, with FY26 operating cash flow improving by $5.9 million year-on-year, supported by 31% growth in branded B2C revenue and continued progress across Germany, New Zealand and Poland. Covered by Stockhead and Cannabiz.
Babylon Pump & Power (ASX: BPP) launched a partially underwritten $12.7 million non-renounceable rights issue to recapitalise the business, fund fleet expansion and support the next phase of growth in its specialist water management rental business.
ENERGY
Energy World Corporation (ASX: EWC) released its June quarterly, confirming the US$350 million turbine sale remains on schedule while outlining continued commercial engagement for its Pagbilao LNG terminal as part of the company's ongoing strategic review.
Hazer Group (ASX: HZR) reported for the quarter ended 30 June 2026 that it completed its Process Design Package with KBR, accelerating commercial engagement across steel, ammonia, clean fuels and industrial sectors, while advancing the FortisBC project in Canada, progressing graphite monetisation via its Hallett agreement, and entering the SAF/renewable diesel market through an MOU with Continuous Renewable Ventures, underpinned by a robust $13.0m funding position.
Galilee Energy (ASX: GLL) has intersected the Homeseeker B sand on prognosis at approximately 8,946 ft TVD in its Zydeco-1 well in Acadia Parish, Louisiana, with continuous high-pressure gas readings indicating strong hydrocarbon presence. Thickness and clean-sand development are comparable to the MacCabees B-1 offset well, further de-risking project economics as these sands were not included in the Zydeco-1 financial model. Drilling continues to the primary Tweedel Sand target, with Zydeco-1 testing unrisked prospective resources of up to 13.7 Bcf of gas and 610,000 barrels of condensate.
BIOTECH
Syntara (ASX: SNT) advanced its Phase 1b AZALOX trial of amsulostat in high-risk myelodysplastic neoplasms (MDS) and chronic myelomonocytic leukaemia (CMML), after completing the first dose cohort with no dose-limiting toxicities or new treatment-related adverse events. The independent safety board has approved escalation to the final dose cohort, with all 10 German trial sites now recruiting and preliminary Phase 1b data expected in Q4 2026.
Radiopharm Theranostics (ASX: RAD) announced positive data from all 30 evaluable patients in the Phase 2b trial of RAD101 in participants with suspected recurrence of brain metastases after radiotherapy. Analysis of the imaging data for all assessed lesions showed 93% concordance between MRI and PET imaging of brain metastases in this patient population with suspected recurrence. Additionally, 14 patients with evaluable six-month follow-up and/or biopsy data show preliminary 86% sensitivity.
Radiopharm also shared positive clinical results from the first two patients in the third cohort of RAD204, its investigational PD-L1-targeted lutetium-177 nanobody radiotherapeutic being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors in a post-immunotherapy setting. Both patients remain on treatment, and initial clinical observations from the ongoing study support the potential of repeated administration of RAD204. Covered by Stockhead and Biotech Dispatch.
Imricor (ASX: IMR) submitted its NavTrac and NavTrac-MR® Steerable Introducers for market clearance under the U.S. Food and Drug Administration’s (FDA’s) 510(k) premarket notification pathway. The NavTrac and NavTrac-MR are steerable introducer sets, each comprising a bi-directionally-steerable sheath and an associated vascular dilator. In total, Imricor has completed 14 of the 15 FDA submissions required to establish its full product platform for commercialisation in the U.S., the world's largest electrophysiology market.
BLS Pharmaceuticals (ASX: BLS) secured an international Referral Agreement with Cayman Chemical Company, a leading global supplier of pharmaceutical-grade active pharmaceutical ingredients (APIs) expanding the Company's international commercial platform and strengthening its position in the emerging global psychedelic therapeutics market. The company also signed a non-binding Heads of Agreement with Australian biopharmaceutical company Trexapharm Pty Ltd to explore the potential commercialisation of TREXAVIVE®, a proprietary, patented neurotherapy developed for the treatment of treatment-resistant depression. Under the proposed collaboration, BLS would be appointed Trexapharm’s preferred Australian commercial partner, providing support to psychiatrists, clinics, and patient access pathways to facilitate greater availability of the therapy. Covered by Stockwire.
AGRICULTURE
RLF AgTech (ASX: RLF) is advancing its commercial growth strategy to diversify revenue and strengthen earnings resilience. The Company's rebuilt Australian sales function has generated approximately $690,000 in customer receipts since February 2026, a six-fold increase on the prior corresponding period, while its corporate grower program continues to validate adoption of the Axioma Biologicals range.
CORPORATE NEWS
Kalamazoo Resources (ASX: KZR) received strong investor support for an oversubscribed $8 million placement, with funds to accelerate resource growth and extension drilling, advance the updated Mineral Resource Estimate and Pre-Feasibility Study at the Ashburton Gold Project. Directors have committed to participate for $158,000 subject to shareholder approval. Covered by Australian Resources and Investment and Mining.com.au.
AnteoTech (ASX: ADO) appointed Scott Waddell as Chief Financial Officer and Company Secretary on a fixed-term contract through to December 2028, following his tenure as Interim CFO since February 2026. Mr Waddell brings more than 30 years of corporate finance experience across ASX-listed and international resource companies and will support AnteoTech as it continues executing its commercialisation strategy across its Advanced Battery Technologies and Life Sciences businesses.
Richmond Vanadium Technology (ASX: RVT) appointed Seth McCann as General Manager, Development, Approvals & Studies, strengthening its leadership team as the Richmond-Julia Creek Vanadium Project advances toward development. With more than 20 years' experience in environmental management and project approvals, Mr McCann will lead completion of the Environmental Impact Statement, regulatory approvals and stakeholder engagement, supporting the project's next stage of development and planned Bankable Feasibility Study.
Power Minerals (ASX: PNN) appointed New York-based entrepreneur and investor Israel "Izzy" Benchemhoun as a Non-Executive Director, strengthening the company's access to US capital markets as it advances the Morro do Ferro Rare Earths Project in Brazil. Mr Benchemhoun's appointment is expected to support engagement with strategic US investors, broaden Power's international shareholder base and assist as the company assesses a potential NASDAQ listing, while drilling at Morro do Ferro continues with initial assay results pending.
Lincoln Minerals (ASX: LML) appointed Alexander Ji as a Non-Executive Director, strengthening the board with more than 20 years' experience in corporate finance, mergers and acquisitions, and strategic investments. Mr Ji is also a director of Prosperity Success Holdings, the strategic investor that participated in Lincoln's recent capital raising, supporting the company's next phase of growth.
Middle Island Resources (ASX: MDI) appointed Stefan Mojićević as Country Manager, strengthening its Serbian-based leadership team. Mr Mojićević brings more than 10 years' experience in Serbian legal, regulatory and permitting matters. He joins Middle Island from Rio Tinto, where he served for over three years as Principal Permitting Advisor on the Jadar Lithium Project, leading land acquisition and environmental permitting activities while working closely with Serbian government authorities and local stakeholders. Covered Mining.com.au.
Green Technology Metals (ASX: GT1) appointed Peter Nazareth as Chief Executive Officer effective 17 August 2026. Mr Nazareth brings extensive experience in corporate development, strategic finance and investment evaluation, further strengthening Green Technology Metals' leadership team as the Company advances its North American lithium development strategy.
Paradigm Biopharmaceuticals (ASX: PAR) received a $4,817,677 Research & Development Tax Incentive refund relating to the financial year ended 30 June 2025, inclusive of $59,579 of interest earned. In addition, the Company has received $927,317 (including interest of $85,083) following an amended income tax assessment relating to the financial year ended 30 June 2023. The combined cash receipts of approximately $5.75 million further strengthen the Company's balance sheet as it continues to execute its strategic priorities, including progressing its pivotal Phase 3 clinical program evaluating injectable pentosan polysulfate sodium for the treatment of knee osteoarthritis and supporting ongoing regulatory and New Drug Application activities.
PainChek Ltd (ASX: PCK) received a $1.123 million research and development tax incentive refund for the 2025 financial year. The refund relates to R&D undertaken in support of PainChek’s core focus on advancing and commercialising its AI-enabled pain assessment platform. The eligible work included continued development of the PainChek Adult and Infant algorithms, together with validation activities supporting the Company’s entry into the US market and the expansion of its technology for use in children.